Cite

HARVARD Citation

    Xu, R. et al. (2022). Targeted inhibition of HER-2 positive breast cancer cells by trastuzumab functionalized pullulan-doxorubicin nanoparticles. Polymer testing. p. . [Online]. 
  
Back to record